Copyright © 2006 Elsevier Ltd All rights reserved.
Update
Research Focus
Engineered chloroplasts as vaccine factories to combat bioterrorism
Available online 11 July 2006.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Bacillus anthracis is ideal for making biological weapons, but the licensed anthrax vaccine is unsuitable for widespread public administration. Recombinant subunit-vaccine candidates offer potential alternatives, and plant-based production systems facilitate the inexpensive bulking of target antigens. A recent report demonstrates expression of anthrax protective antigen in tobacco chloroplasts – this material is immunogenic and protective when injected into mice. Provided an economic purification scheme can be developed, this technology holds promise for an improved vaccine.






E-mail Article
Add to my Quick Links

Cited By in Scopus (2)





